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Summary
This simulation-based report compares the performance of ﬁve methods of association analysis in the presence of linkage
using extended sibships: the Family-Based Association Test (FBAT), Empirical Variance FBAT (EV-FBAT), Conditional
Logistic Regression (CLR), Robust CLR (R-CLR) and Sibship Disequilibrium Test (SDT). The two tests accounting
for residual familial correlation (EV-FBAT and R-CLR) and the model-free SDT showed correct test size in all simulated
designs, while FBAT and CLR were only valid for small effect sizes. SDT had the lowest power, while CLR had the
highest power, generally similar to FBAT and the robust variance analogues. The power of all model-dependent tests
dropped when the model was misspeciﬁed, although often not substantially. Estimates of genetic effect with CLR and
R-CLR were unbiased when the disease locus was analysed but biased when a nearby marker was analysed. This study
demonstrates that the genetic effect does not need to be extreme to invalidate tests that ignore familial correlation and
conﬁrms that analogous methods using robust variance estimation provide a valid alternative at little cost to power.
Overall R-CLR is the best-performing method among these alternatives for the analysis of extended sibship data.
Keywords: Extended sibships, conditional logistic regression, robust variance, simulation.
Introduction
Family-based association tests are tools of genetic association
analysis robust to confounding effects of population stratiﬁ-
cation, a recurrent problem in classical case-control designs.
The most popular family-based association test, the Transmis-
sion Disequilibrium Test or TDT, was originally designed to
test for distortion in genetic transmission between parents and
theiraffectedoffspring(Spielmanetal.1993).Ithassincebeen
extended to other family and trait types by different authors
(e. g. Allison, 1997; Spielman & Ewens, 1998; Clayton, 1999;
Abecasis et al. 2000). Probably the most comprehensive ex-
tensionistheFamily-BasedAssociationTest(FBAT)approach
(Rabinowitz & Laird, 2000) implemented in the popular
software of the same name (www.biostat.harvard.edu/∼fbat).
This method can be applied to both dichotomous and quanti-
tative phenotypes in a variety of family types regardless of the
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structure of missing data, and multiple relatives are used while
accounting for correlation in allele transmission among them
(Lake et al. 2000). The ability to analyse families where par-
ents are missing is of particular interest for late onset diseases
where the parents of a proband have generally died. Account-
ing for correlation in allele transmission among siblings due
to genetic linkage is important when multiple siblings are
affected. In fact, while this correlation has no impact when
the null hypothesis is ‘no linkage and no association’,i td o e s
induce spurious association when the null is ‘linkage but no
association‘ (Martin et al. 2000; Lake et al. 2000). Previously
some authors had proposed to resolve the problem of residual
familial correlation by selecting only one affected per family
(Curtis, 1997), but this approach is clearly inefﬁcient. Lake
et al. (2000) proposed to account for residual familial cor-
relation by using an empirical variance-covariance estimator
in place of the classical variance-covariance matrix used in
standard FBAT, giving a new test that they termed EV-FBAT
(option –e in FBAT program).
Conditional logistic regression (CLR, available in most
statistical software e.g. SAS, SAS Institute Inc., Cary, NC,
USA, and STATA, StataCorp, 2005) is a traditional method of
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analysis of matched case-control studies in epidemiology. This
is also appropriate for testing genetic association using fa-
milial data (Siegmund et al., 2000), since the within-family
analysis provides protection against population stratiﬁcation.
In a simulation study, Siegmund et al. (2000) showed that,
although standard CLR (using the Wald test) applied to fam-
ilies of multiple affected siblings is valid in the case of low
genetic effect, it has an inﬂated type 1 error when the lo-
cus has a strong effect. They demonstrated that using the
robust variance-covariance estimator (Rogers, 1993) in place
of classical variance-covariance removes this effect of residual
familial correlation. The new test derived by Siegmund et al.
(2000)byapplyingrobustvariance-covariancewillbereferred
to here as R-CLR (robust conditional logistic regression).
FBAT and EV-FBAT are dedicated to genetic association
analysis while CLR and R-CLR are more general methods
available in general software. They have important distinctive
features such as the straightforward extension to haplotypes
in FBAT which is unavailable for general programs (haplo-
types have to be externally reconstructed to be analysed with
CLR/R-CLR, see e.g. Nsengimana et al. 2007). On the
other hand, additional risk factors and their interactions can
be easily incorporated in the CLR/R-CLR approach, while
they can only be indirectly considered in FBAT/EV-FBAT
(by separate regression analysis and application of FBAT/EV-
FBAT to residuals of this regression, see e.g. Lu & Cantor,
2007). In addition, CLR/R-CLR allow estimation of the
size of genetic effect in terms of the odds ratio, which is not
feasible in FBAT.
To our knowledge there is no published study comparing
FBAT and EV-FBAT in a large range of family designs and
disease models and showing the effectiveness and cost of em-
pirical variance in removing the effect of residual familial cor-
relation. Likewise, there is no published study comparing the
power of FBAT/EV-FBAT and CLR/R-CLR approaches.
Here we report on a simulation study comparing type 1 er-
ror rate, power, bias and robustness to model misspeciﬁcation
associated with these methods when testing for association in
the presence of linkage using extended sibships. We consider
a mixture of sibship sizes and structures (numbers of affected
and unaffected siblings) in the absence of parental data. Be-
cause the true genetic model is generally unknown, it may
be preferable to use a method that does not make any as-
sumptions about the mode of inheritance. For this reason,
we further compare the power of all these model-based tests
(FBAT, EV-FBAT, CLR and R-CLR) under correct and in-
correct models with the Sibship Disequilibrium Test (SDT,
Horvath & Laird, 1998), a model-free sign test contrasting the
number of sibships where a particular allele is more common
in affected versus unaffected siblings. SDT has been shown
to be less powerful than CLR and R-CLR under a cor-
rect genetic model (Siegmund et al. 2000) but we investigate
whether SDT is still inferior when the model is misspeciﬁed.
Methods
Five methods are compared: FBAT, EV-FBAT, CLR, R-CLR
and SDT. Firstly the type 1 error rate of all ﬁve tests is evaluated
usingavarietyoffamilydesignsanddiseasemodelsandthepower
is compared wherever the size of the test is correct. Secondly, for
tests requiring a genetic model speciﬁcation (FBAT, EV-FBAT,
CLR and R-CLR) robustness to model misspeciﬁcation is as-
sessed by calculating power assuming a dominant and a recessive
model with data simulated using an additive model. Also, since
there is generally no guarantee that the polymorphism under in-
vestigation is the actual disease locus, situations are considered in
power estimation where they coincide and are maximally associ-
ated (D’ = 1.0) and where they are at a certain (small) distance
from each other and linkage disequilibrium (LD) between them
is weaker (D’ = 0.5). As CLR and R-CLR allow estimation of
the strength of genetic effect, the bias of this estimate is evaluated
when the tested locus is the disease locus and when it is a nearby
marker. Nicodemus et al. (2007) have recently compared TDT-
derived methods in an attempt to draw some guidelines on how
to choose the appropriate test according to the data or how to
design the study in order to apply a particular test. Unlike these
authors who compared the methods that use different types of
data, here the experimental design is ﬁxed a priori as discordant
sibships with missing parents, with the common situation of late
onset diseases in mind.A mixture of sibship sizes are consid-
ered with variable numbers of affected and unaffected siblings.
The family structures simulated are based on those found in a
cardiovascular disease candidate-gene study (Nsengimana et al.
2007).
Simulated Designs
A dichotomous disease outcome is considered, and for each de-
sign (Table 1) 10,000 replicates are simulated. For type 1 error
evaluation, the marker and disease locus were linked but not
associated, i.e. they were in linkage equilibrium. For most de-
signs the recombination fraction θ was set to the most extreme
value of zero, since the tighter the linkage the more inﬂation of
type 1 error is expected. For the more extreme designs (12 and
13), where some inﬂation of type 1 error was seen (see Results),
θ was varied between 0 and 0.5 to examine the effect of weaker
linkage. For power estimation, two situations were considered:
marker = disease locus and distance from marker to disease locus
equals 50kb (recombination rate θ = 0.0005, assuming 1Mb ≈
1cM) with D’ = 0.5 (r2 = 0.25). This level of LD at this distance
was chosen because an average D’ of 0.50 has been observed
at ∼50kb in 19 randomly selected regions across the human
genome (Reich et al. 2001). We ﬁxed the distance between the
marker and the gene locus because we deﬁned the LD level in the
parental generation, whereas the analysis is done in the offspring
generation. The LD decreases between the two generations but
the low distance chosen means that the decrease is negligible. In
all designs, the marker and disease locus were biallelic and had
equal minor allele frequency ranging from 0.10 to 0.50. At the
disease locus, the susceptibility allele was the one with lowest
frequency. The additive genetic model (on the logistic scale) was
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Table 1 Designs simulated to assess type 1 error and power
Design fD (1) PDD (2) PND (3) PNN (4) GOR (5) Prev (6) PAF (7)
1 0.10 0.31 0.25 0.20 1.33 21 5
2 0.30 0.31 0.25 0.20 1.33 23 13
3 0.10 0.51 0.40 0.30 1.55 32 6
4 0.30 0.51 0.40 0.30 1.55 36 17
5 0.10 0.42 0.30 0.20 1.71 22 9
6 0.30 0.42 0.30 0.20 1.71 26 24
7 0.10 0.39 0.25 0.15 1.89 17 12
8 0.30 0.39 0.25 0.15 1.89 21 30
9 0.10 0.64 0.40 0.20 2.67 24 17
10 0.30 0.64 0.40 0.20 2.67 32 38
11 0.10 0.84 0.60 0.30 3.5 36 17
12 0.30 0.84 0.60 0.30 3.5 47 37
13 0.50 0.90 0.50 0.10 9 50 80
(1) Frequency of disease allele D and minor allele frequency at the marker locus; (2) Penetrance in homozygous carriers; (3) Penetrance in
heterozygotes; (4) Incidence in non-carriers; (5) Genetic odds ratio per copy of disease allele; (6) Disease prevalence in the population (%);
(7) Population-attributable fraction (%).
Table 2 Numberandstructureofsimulatedsibshipsforpowercom-
parison
Sibship size 2 3 3 4 4 5 5
Affected 1 1 2 2 3 2 3
Unaffected 1 2 1 2 1 3 2
Number of sibships 200 450 200 50 60 20 20
Table 3 Number and structure of sibships simulated for type 1 error
evaluation
Sibship size 5 5 6 6 6
Affected 3 4 3 4 5
Unaffected 2 1 3 2 1
Number of sibships 150 250 150 400 50
simulated, and genotype penetrances were varied from 0.10 to
0.90, giving overall population prevalence of the disease between
17 and 50% with population-attributable fraction (PAF) of the
locus ranging between 5 and 80% and genetic odds ratio (GOR)
of 1.3 to 9 per copy of variant allele (Table 1). These parame-
ters were chosen to be consistent with a common disease model
with small to high GOR from the locus of interest, the highest
values being set to assess the behaviour of the tests in extreme
situations.
For power calculations, a total of 1,000 sibships were sim-
ulated with ﬁxed proportions of various numbers of affected
and unaffected siblings (Table 2) close to the proportions in our
cardiovascular study. For type 1 error evaluation, larger sibships
were considered (Table 3) to allow for a higher impact of familial
correlation. The simulated data were analysed within the FBAT
program for tests FBAT, EV-FBAT and SDT, while STATA v.9
(StataCorp, 2005) was used for CLR and R-CLR (testing for as-
sociation using the Wald test). The simulation program (written
in C) is available upon request.
Results
Type 1 Error Rate
Because most genetic association studies involve testing mul-
tiple hypotheses, we report test size and power at the 0.001
level. In all the designs with GOR<2, all ﬁve tests have cor-
rect size as shown in Table 4. In all the designs with GOR>2,
FBAT and CLR showed signiﬁcantly inﬂated type 1 error,
while SDT, EV-FBAT and R-CLR remained valid. For the
two most extreme designs (designs 12 and 13), simulations
were carried out with different distances between the marker
and the susceptibility locus. In both designs, type 1 error in-
ﬂation in FBAT and CLR was higher with tighter linkage
(Table 4), remaining signiﬁcant at a recombination fraction
of 0.10 in design 12 (GOR = 3.5/PAF = 37%) and 0.20 in
design 13 (GOR = 9/PAF = 80%).
Power Comparison when the Correct Model is
Used
Power is compared between the 5 methods in the designs
where they all showed correct test size (those with GOR<2,
see Table 4). In order to assess any loss of power due to
correcting for familial correlation for a stronger locus effect,
the power of all tests is also compared in designs 9 and 10
where the tests using the standard variance-covariance matrix
showed inﬂated type 1 error (designs with GOR = 2.67). As
shown in Table 5, FBAT, EV-FBAT, CLR and R-CLR have
comparable powers in all designs, while SDT is consistently
less powerful. At the 0.001 signiﬁcance level all tests have a
poor power (<20%) in the design of weakest genetic effect
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Table 4 Type 1 error at level 0.001
Design (1) PAF (%) GOR FBAT EV-FBAT CLR R-CLR SDT
1 5 1.33 0.0004 0.0005 0.0003 0.0006 0.0006
2 13 1.33 0.0005 0.0006 0.0008 0.0008 0.0005
3 6 1.55 0.0012 0.0008 0.0011 0.0010 0.0011
4 17 1.55 0.0012 0.0010 0.0007 0.0009 0.0006
5 9 1.71 0.0013 0.0009 0.0015 0.0011 0.0007
6 24 1.71 0.0010 0.0005 0.0012 0.0009 0.0004
7 12 1.89 0.0013 0.0007 0.0011 0.0007 0.0008
8 30 1.89 0.0015 0.0007 0.0014 0.0013 0.0008
9 17 2.67 0.0027∗∗ 0.0013 0.0022∗∗ 0.0015 0.0008
10 38 2.67 0.0027∗∗ 0.0014 0.0019∗ 0.0014 0.0009
11 17 3.5 0.0020∗ 0.0010 0.0025∗∗ 0.0013 0.0007
12
θ = 0.0 0.0033∗∗ 0.0014 0.0026∗∗ 0.0015 0.0015
θ = 0.1 0.0021∗ 0.0010 0.0018∗ 0.0008 0.0006
θ = 0.2 37 3.5 0.0012 0.0005 0.0012 0.0007 0.0007
θ = 0.3 0.0009 0.0007 0.0014 0.0013 0.0010
θ = 0.4 0.0009 0.0008 0.0010 0.0011 0.0009
θ = 0.5 0.0011 0.0009 0.0009 0.0010 0.0004
13
θ = 0.0 0.0046∗∗ 0.0011 0.0052∗∗ 0.0006 0.0008
θ = 0.1 0.0032∗∗ 0.0011 0.0029∗∗ 0.0013 0.0011
θ = 0.2 80 9 0.0017∗ 0.0010 0.0019∗ 0.0008 0.0013
θ = 0.3 0.0015 0.0010 0.0013 0.0009 0.0009
θ = 0.4 0.0013 0.0014 0.0014 0.0013 0.0010
θ = 0.5 0.0011 0.0010 0.0011 0.0012 0.0015
(1) Error 1 rate at increasing distance marker-disease locus for the two most extreme designs. In all other designs there is zero recombination
rate between the marker and disease locus.
(∗) Signiﬁcant inﬂation at level 0.001<p<0.05, and (∗∗)a tl e v e lp <0.001.
(GOR = 1.33/PAF = 5%). Power rises however to over 56%
(40% for SDT) in the same design with a more common
disease allele (GOR = 1.33/PAF = 13%) when the marker
locus coincides with the disease locus. At a GOR of 1.55
and allele frequency 30% (design 4), the power jumps to
∼97% (91% for SDT) when the marker is the disease locus
(Table 5).
The power is lower when disease and marker loci do not
coincide and the LD between them is 50% of the maximum.
It remains lower than 35% for all designs with GOR<2a n d
variantfrequency=10%(designs1,3,5and7),butithits99%
(97% for SDT) in the strongest model analysed. In designs
where GOR = 2.67, valid tests EV-FBAT and R-RCLR
appear to remain as powerful as FBAT and CLR, indicating
that there is little cost to power from using robust variance
even for strong locus effects. However some drop of power
would be expected when robust variance is used, and this
is more apparent when more stringent signiﬁcance levels are
applied, moving the power away from 100%. As can be seen in
Table 6, the power of standard and robust/empirical variance
methods remain of the same magnitude in designs 4 to 8
but robust/empirical variance is associated with substantially
lower power in designs 9 and 10. It also appears that at high
GORsandlowα valuestheR-CLRmethodismorepowerful
than EV-FBAT.
Estimating the Strength of Genetic Effect
CLR and R-CLR offer the possibility of estimating the ge-
netic effect as a GOR. Along with true simulated and esti-
mated GORs, Table 7 shows the proportion of simulations
where the 95% conﬁdence interval (CI) contains the true
value. Both methods give the same estimate of GOR but
have different CIs, as the only difference between them is the
variance they use (i.e. standard vs. robust variance). In all the
designs considered, CLR and R-CLR show an unbiased es-
timate of GOR and good CI coverage as long as the analysed
marker is the disease locus (Table 7). However, as expected,
when LD is reduced the estimate is biased and the 95% CI
coverage is clearly poor. The bias and drop in CI coverage in-
crease with the strength of true genetic effect and the variant
allele frequency. The true value is contained in the 95%CI
in only 3 simulations in 10,000 when GOR = 2.67, variant
frequency = 30% and D’ = 0.5 (design 10).
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Table 5 Power at level 0.001 under the correct model (%)
Design (1) PAF (%) GOR D’ FBAT EV-FBAT CLR R-CLR SDT (2)
1 5 1.33 1.0 16.6 15.9 16.9 16.4 9.9
0.5 1.7 1.6 1.7 1.6 0.9
2 13 1.33 1.0 56.4 55.6 56.5 56.0 39.6
0.5 6.2 6.0 6.3 6.1 3.9
3 6 1.55 1.0 60.5 59.3 61.2 60.1 42.5
0.5 7.0 6.7 7.2 6.8 4.2
4 17 1.55 1.0 97.4 97.3 97.7 97.6 91.3
0.5 25.4 24.6 26.3 25.6 15.8
5 9 1.71 1.0 88.5 87.9 89.0 88.4 76.8
0.5 16.2 15.4 16.4 15.6 10.1
6 24 1.71 1.0 99.9 99.9 99.9 99.9 99.4
0.5 50.6 49.7 51.4 50.0 35.9
7 12 1.89 1.0 98.2 98.1 98.2 98.2 94.5
0.5 33.4 31.9 33.3 31.9 22.8
8 30 1.89 1.0 100 100 100 100 100
0.5 74.6 73.3 74.8 73.6 59.7
9 17 2.67 1.0 100 100 100 100 100
0.5 84.8 83.1 85.5 83.9 70.3
10 38 2.67 1.0 100 100 100 100 100
0.5 99.2 99.2 99.3 99.2 97.1
(1) FBAT and CLR are not valid for the two last designs with GOR = 2.67 (see Table 4).
(2) SDT does not require model speciﬁcation.
Table 6 Power at more stringent signiﬁcance levels under the correct model (%)
Design PAF (%) GOR α D’ FBAT EV-FBAT CLR R-CLR SDT (1)
4 17 1.55 10−5 1.0 80.6 79.3 81.8 81.0 60.1
0.5 3.7 3.3 4.0 3.7 1.9
6 24 1.71 10−7 1.0 88.0 86.6 89.1 87.5 69.9
0.5 2.3 1.9 2.5 2.1 1.0
7 12 1.89 10−5 1.0 84.1 82.4 84.3 82.9 69.0
0.5 5.7 5.0 5.7 5.0 2.8
8 30 1.89 10−10 1.0 90.0 87.4 90.8 88.1 69.5
0.5 0.6 0.4 0.7 0.4 0.1
9 17 2.67 10−12 1.0 85.2 76.3 87.9 80.4 59.8
0.5 0.2 0.1 0.2 0.1 0.1
10 38 2.67 10−25 1.0 80.9 62.0 88.4 71.0 44.4
0.5 0.0 0.0 0.0 0.0 0.0
(1) SDT does not assume a genetic model.
Power Comparison Under an Incorrect Genetic
Model
The data simulated using an additive model were also analysed
with four tests (FBAT, EV-FBAT, CLR, R-CLR) assuming
dominant and recessive models. Under the dominant model,
all four methods remain equally powerful (Table 8). Power
is lower than when the correct model was used but remains
higher or comparable to that of SDT (Tables 5 and 8). The
largest drop in power is observed in designs with a common
disease variant. For example, when the marker is the disease
locus the power of the four tests drops from ∼56% to 37%
in design 2, and where the marker is in LD with the dis-
ease locus (D’ = 0.5), the power drops from ∼74% to 54%
in design 8. When the analysis model is recessive, the power
decreases more sharply for all four tests and it falls below the
power of SDT in all the designs. In contrast to dominant
models, the most dramatic fall is observed in the designs with
smallest disease allele frequency (Table 8) as one might ex-
pect. In design 7 (GOR = 1.89), the highest power in the
four tests hardly reaches 14% where the power of SDT hits
94%.
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Table 7 Estimated genetic odds ratio and conﬁdence interval coverage
Design PAF (%) True GOR D’ Estimated GOR 95CI for 95CI for
CLR (1) R-CLR (1)
1 5 1.33 1.0 1.34 95.1 95.0
0.5 1.17 80.6 80.5
2 13 1.33 1.0 1.34 94.7 94.7
0.5 1.16 62.3 62.4
3 6 1.55 1.0 1.56 95.0 94.9
0.5 1.27 59.4 59.5
4 17 1.55 1.0 1.55 94.9 94.8
0.5 1.25 24.5 24.7
5 9 1.71 1.0 1.72 95.3 95.3
0.5 1.34 48.4 48.7
6 24 1.71 1.0 1.71 95.0 94.9
0.5 1.32 12.4 12.7
7 12 1.89 1.0 1.90 94.9 95.0
0.5 1.43 35.7 36.3
8 30 1.89 1.0 1.90 94.9 94.9
0.5 1.39 4.8 4.9
9 17 2.67 1.0 2.67 95.0 95.0
0.5 1.71 5.5 5.6
10 38 2.67 1.0 2.68 95.3 95.3
0.5 1.64 0.03 0.03
(1) Proportion (%) of simulations where the 95% conﬁdence interval contains the true GOR.
Discussion
Family-based association methods were originally designed
to test for the presence of linkage or association. While test-
ing this composite null hypothesis can be interesting in some
instances, many candidate gene ﬁne-mapping studies aim to
search for association in a region where linkage has already
been found or where it can be reasonably assumed. There-
fore, the methods that can test association in families while
accounting for linkage are valuable tools. In this study, we
compare the performances of ﬁve methods of family-based
association analysis: FBAT, EV-FBAT, CLR, R-CLR and
SDT. Our study shows that in the case of low genetic risk
all ﬁve tests have a correct type 1 error rate (Table 4). How-
ever, for genes with a GOR higher than 2, FBAT and CLR
have an inﬂated type 1 error while their counterparts using
robust variance estimation remain valid. For CLR and R-
CLR, our observations conﬁrm those made by Siegmund et
al. (2000), although the two studies bear some differences. In
their study, Siegmund et al. (2000) used 200 and 500 sibships
of size 3 and 4, assessed test validity at GOR = 2a n d2 0( l o g
additive model) and used a nominal p-value of 0.05. They
concluded that ‘the genetic effect needs to be quite extreme before
residual familial correlation due to linkage led to false positive in-
ference’ using CLR. In our study, we found that CLR is not
valid (level 0.001) for a GOR of 2.67 which is far less extreme
than 20. Our study demonstrates that familial correlation is
not only inﬂuenced by the strength of the genetic effect, but
also, maybe more critically, by the number of affected siblings
within a family. Robust variance should therefore be recom-
mended in the analysis of large sibships even when a modest
genetic effect is suspected.
Our study of power conﬁrms the results of Siegmund et al.
(2000) and Hancock et al. (2007) that robust variance resolves
the problem of familial correlation at little or no cost to power
in CLR for most practical situations, and we make a similar
observation with FBAT. However, when GOR is high, robust
variance induced a substantial power loss to both FBAT and
CLRatstringentsigniﬁcancelevels(movingpowerawayfrom
100%). Also, while EV-FBAT and R-CLR showed compa-
rable power at level 0.001 in all simulated designs, R-CLR
appears as the most powerful test at very low alpha values.
Combined with the ﬂexibility of this method (for example
the ease of adding covariates, testing for interactions and esti-
mating the strength of genetic effects), this result suggests that
R-CLR is a better choice than EV-FBAT for the analysis of
extended sibship data.
All the tests compared under incorrect genetic model spec-
iﬁcation have shown similar results: with the additive model
simulated, a small drop in power when the dominant model
is assumed and a sharper power decrease with the recessive
model (Table 8). Unsurprisingly, the rarer the disease allele,
the more pronounced the loss of power under the recessive
model. In effect, only the homozygous affecteds contribute
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Table 8 Power at level 0.001 using an incorrect model
Model (1) Design PAF (%) GOR D’ FBAT EV-FBAT CLR R-CLR
Dominant 1 5 1.33 1.0 13.7 13.6 13.8 13.3
0.5 1.6 1.5 1.6 1.5
2 13 1.33 1.0 36.6 36.8 36.7 36.2
0.5 3.7 3.9 3.7 3.6
3 6 1.55 1.0 54.8 53.8 55.3 54.3
0.5 6.1 5.8 6.2 5.8
4 17 1.55 1.0 89.5 89.5 89.9 89.5
0.5 15.4 15.0 16.0 15.6
5 9 1.71 1.0 84.0 84.0 84.2 83.7
0.5 14.0 13.4 14.2 13.4
6 24 1.71 1.0 98.9 98.9 99.0 98.9
0.5 33.0 32.7 33.2 32.2
7 12 1.89 1.0 96.6 96.5 96.7 96.6
0.5 29.0 28.1 29.2 27.9
8 30 1.89 1.0 99.9 99.9 99.9 99.9
0.5 54.2 53.9 54.3 53.0
Recessive 1 5 1.33 1.0 0.8 0.3 0.9 0.2
0.5 0.2 0.1 0.4 0.0
2 13 1.33 1.0 13.0 11.4 12.7 12.2
0.5 1.4 1.1 1.4 1.2
3 6 1.55 1.0 2.2 0.8 2.2 0.8
0.5 0.5 0.1 0.5 0.1
4 17 1.55 1.0 47.2 43.8 49.4 47.7
0.5 4.5 3.9 4.8 4.3
5 9 1.71 1.0 5.8 2.6 6.1 3.4
0.5 0.7 0.3 0.8 0.4
6 24 1.71 1.0 80.1 77.6 81.0 80.1
0.5 10.9 9.3 11.0 10.5
7 12 1.89 1.0 13.3 7.6 13.8 9.7
0.5 1.5 0.6 1.4 0.7
8 30 1.89 1.0 96.6 95.9 96.5 96.3
0.5 21.2 18.2 20.9 19.7
(1) This is the analysis model. The simulated model is additive in all the designs.
to the test, and their number is very small even for rela-
tively common alleles. Although SDT was the least powerful
method when the model is correctly speciﬁed in the other
tests (Table 5), it is actually more powerful than any other
test in all simulated designs when the analysis assumes (incor-
rectly) a recessive model. SDT may therefore be preferable to
other tests in some instances or, alternatively, it can be used
in addition to EV-FBAT or R-CLR. In such a case, a highly
signiﬁcant association found with SDT undetected by other
approaches would suggest wrong model speciﬁcation.
CLR and R-CLR provide precise estimates of the GOR
when the marker is the disease locus. However, as expected,
when the marker and the disease loci are distinct and are not
maximally associated, the estimate of GOR is always biased
and the 95% CI coverage can be very poor. The stronger the
true genetic effect and the commoner the disease allele fre-
quency, the higher the bias. Cordell (2004) reported a similar
observation using a CLR method based on conditioning on
parental genotypes (using parents and their affected offspring).
The bias increased with the number of affected siblings and
with the size of true genetic effect. More recently, Hancock
et al. (2007) reported the same bias using R-CLR and gen-
eralised estimating equations. They showed that generalised
estimating equations are even more biased than R-CLR, par-
ticularly for gene x gene interaction effects. In our study, the
bias was inﬂuenced by LD, the true strength of genetic effect
and the allele frequency. Missing parental genotypes do not
appear to be a source of bias, since bias was also found when
parents were used (Cordell, 2004; Hancock et al. 2007).
Our study has some limitations. First, this is not a compre-
hensiveevaluationofallexistingfamily-basedassociationtests.
There are now many methods, most of which were optimised
for particular data conﬁgurations and are not necessarily per-
fectly comparable. We chose to focus on one general statistical
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approach (CLR) and one specialised genetic method (FBAT)
both of which are very widely used for sibship data. Sec-
ond, a comprehensive comparison would necessitate a larger
spectrum of family structures, sample sizes and disease mod-
els (genetic effect, allele frequency, linkage disequilibrium,
etc.), not all of which would be feasible to consider in one
study. We chose instead to concentrate on one large mix-
ture of family structures as observed in an actual study of
affected and unaffected siblings with cardiovascular disease
(Nsengimana et al. 2007). Although this design only repre-
sents one type of study, a mixture of family structures (sibship
sizes + numbers of affected/unaffected) is common and is
therefore in this context more realistic than the range of ho-
mogeneous designs often considered (e.g. Siegmund et al.
2000, Martin et al. 2000).
In conclusion, our simulations show that the genetic effect
does not need to be extreme to invalidate tests that use stan-
dard variance estimators (CLR and FBAT). For more com-
plex pedigrees EV-FBAT has clear advantages, but, based on
power, validity and robustness to model misspeciﬁcation, R-
CLR provides a powerful suitable alternative for the analysis
of extended sibships.
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